Cargando…

Phase 1 Renal Impairment Trial Results Supports Targeted Individualized Dosing of ELX‐02 in Patients With Nephropathic Cystinosis

The aim of this study was to assess the pharmacokinetics (PK) and safety of ELX‐02 in a renally impaired population and apply these findings to the individualized dosing of patients with nephropathic cystinosis. This phase 1 renal impairment (RI; mild, moderate, or severe), single‐dose, PK, and safe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haverty, Thomas, Wyatt, David J., Porter, Kaela M., Leubitz, Andi, Banks, Kate, Goodyer, Paul, Hu, Ming‐Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Special Populations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248099/ https://www.ncbi.nlm.nih.gov/pubmed/33355924 http://dx.doi.org/10.1002/jcph.1807

Ejemplares similares

A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy Subjects
por: Leubitz, Andi, et al.
Publicado: (2021)

The novel aminoglycoside, ELX-02, permits CTNS(W138X) translational read-through and restores lysosomal cystine efflux in cystinosis
por: Brasell, Emma J., et al.
Publicado: (2019)

Improving the prognosis of nephropathic cystinosis
por: Besouw, Martine TP, et al.
Publicado: (2014)

Neurological impairment in nephropathic cystinosis: motor coordination deficits
por: Trauner, Doris A., et al.
Publicado: (2010)

Hirschsprung's disease with infantile nephropathic cystinosis
por: Mittal, Deepak, et al.
Publicado: (2015)

Muscle and Bone Impairment in Infantile Nephropathic Cystinosis: New Concepts
por: Haffner, Dieter, et al.
Publicado: (2022)

Analysis of CTNS gene transcripts in nephropathic cystinosis
por: Taranta, Anna, et al.
Publicado: (2010)

Testicular function in males with infantile nephropathic cystinosis
por: Rohayem, J, et al.
Publicado: (2021)

In Vitro and In Vivo Models to Study Nephropathic Cystinosis
por: Cheung, Pang Yuk, et al.
Publicado: (2021)

Genetic Landscape of Nephropathic Cystinosis in Russian Children
por: Savostyanov, K. V., et al.
Publicado: (2022)

Biomarkers in Nephropathic Cystinosis: Current and Future Perspectives
por: Emma, Francesco, et al.
Publicado: (2022)

Pregnancy and Breastfeeding in Nephropathic Cystinosis With Native Kidneys
por: Chan, Lillian, et al.
Publicado: (2022)

Population pharmacokinetics and pharmacodynamics of cysteamine in nephropathic cystinosis patients
por: Bouazza, Naïm, et al.
Publicado: (2011)

Clinical utility of chitotriosidase enzyme activity in nephropathic cystinosis
por: Elmonem, Mohamed A, et al.
Publicado: (2014)

Bone Disease in Nephropathic Cystinosis: Beyond Renal Osteodystrophy
por: Machuca-Gayet, Irma, et al.
Publicado: (2020)

Benefits and Toxicity of Disulfiram in Preclinical Models of Nephropathic Cystinosis
por: Taranta, Anna, et al.
Publicado: (2021)

Muscle wasting and adipose tissue browning in infantile nephropathic cystinosis
por: Cheung, Wai W., et al.
Publicado: (2015)

Nephropathic Cystinosis: Symptoms, Treatment, and Perspectives of a Systemic Disease
por: Bäumner, Sören, et al.
Publicado: (2018)

Autonomic Nervous System Dysregulation in Monozygous Twins With Nephropathic Cystinosis
por: Brooks, Ellen R., et al.
Publicado: (2018)

Asymmetrical Ocular Manifestations of Nephropathic Cystinosis; A Case Report
por: Helmi, Hala A., et al.
Publicado: (2019)

Mitochondrial Dynamics of Proximal Tubular Epithelial Cells in Nephropathic Cystinosis
por: De Rasmo, Domenico, et al.
Publicado: (2019)

Nephropathic Cystinosis: Pathogenic Roles of Inflammation and Potential for New Therapies
por: Elmonem, Mohamed A., et al.
Publicado: (2022)

Substrate Specificity of the Lanthipeptide Peptidase ElxP and the Oxidoreductase ElxO
por: Ortega, Manuel A., et al.
Publicado: (2014)

Multisystem involvement, defective lysosomes and impaired autophagy in a novel rat model of nephropathic cystinosis
por: Krohn, Patrick, et al.
Publicado: (2022)

Diagnosis of Nephropathic Cystinosis in a Child During Routine Eye Exam
por: Ecel, Mahmut, et al.
Publicado: (2017)

Evaluation of the Pharmacokinetics and Safety of a Single Dose of Acalabrutinib in Subjects With Hepatic Impairment
por: Xu, Yan, et al.
Publicado: (2022)

Ventricular noncompaction in a female patient with nephropathic cystinosis: a case report
por: Ahmed, Ibrar, et al.
Publicado: (2009)

Nephropathic cystinosis associated with cardiomyopathy: A 27-year clinical follow-up
por: Dixit, Mehul P, et al.
Publicado: (2002)

Diagnostic challenge in a patient with nephropathic juvenile cystinosis: a case report
por: Higashi, Satomi, et al.
Publicado: (2017)

Patients With Infantile Nephropathic Cystinosis in Germany and Austria: A Retrospective Cohort Study
por: O'Connell, Nina, et al.
Publicado: (2022)

Posterior segment optical coherence tomography findings in a case of nephropathic cystinosis
por: Al Abdulsalam, Omar
Publicado: (2020)

Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to “A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis”)
por: Langman, Craig B.
Publicado: (2023)

Pharmacokinetics and Safety of a Single Oral Dose of Mirogabalin in Japanese Subjects With Varying Degrees of Renal Impairment
por: Kato, Manabu, et al.
Publicado: (2017)

Single‐Dose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With End‐Stage Renal Disease Requiring Hemodialysis
por: Zomorodi, Katie, et al.
Publicado: (2019)

Maribavir Pharmacokinetics and Safety in Participants With Moderate Hepatic Impairment: A Phase 1, Open‐Label, Single‐Dose, Parallel Group Study
por: Song, Ivy, et al.
Publicado: (2022)

Atypical onset of nephropathic infantile cystinosis in a Russian patient with rare CTNS mutation
por: Anastasiya, Kozina A., et al.
Publicado: (2018)

Worldwide view of nephropathic cystinosis: results from a survey from 30 countries
por: Bertholet-Thomas, Aurélia, et al.
Publicado: (2017)

A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis
por: van Stein, Christina, et al.
Publicado: (2021)

Targeting interleukin‐1 for reversing fat browning and muscle wasting in infantile nephropathic cystinosis
por: Cheung, Wai W., et al.
Publicado: (2021)

Pharmacokinetics of serelaxin in patients with severe renal impairment or end‐stage renal disease requiring hemodialysis: A single‐dose, open‐label, parallel‐group study
por: Dahlke, Marion, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_l1mkat4efp4c3222c936q3o1ok